Product Information
HYDRALAZINE 100 MG TABLET is a generic product labeled by Modavar Pharmaceuticals LLC, priced at $0.0717 per EA under NDC 72241000605. Its NADAC has been published 102 times since Oct 23, 2024.
FDA first approved this application on Sep 18, 2014. Its Orange Book therapeutic-equivalence code is AA.
Strength
100 mg/1
Manufacturer
Modavar Pharmaceuticals LLCNDC
72241000605
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDRALAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203845FDA Approved
9/18/2014
TE Code
AA
On Market Since
12/29/2015
Pharmacological Classes
Price Statistics
The NADAC for HYDRALAZINE 100 MG TABLET has been published 102 times since Oct 23, 2024, and over the history we have for it it has declined 13.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0717 per EA |
|---|---|
| All-time high | $0.0832 (Nov 13, 2024) |
| All-time low | $0.0618 (Nov 20, 2024) |
| 52-week high | $0.0792 |
| 52-week low | $0.0717 |
| Median price | $0.0769 |
| Average price | $0.0768 |
| Largest weekly change | -25.7% (Nov 20, 2024) |
| Weeks tracked | 102 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the hydralazine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Modavar Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hydralazine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Arteriolar Vasodilator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDRALAZINE 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDRALAZINE 100 MG TABLET, manufactured by Modavar Pharmaceuticals LLC, is $0.0717 per EA (NDC 72241000605), effective Sep 30, 2026.
How has the price of HYDRALAZINE 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDRALAZINE 100 MG TABLET has declined 13.8%. It has been tracked across 102 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for HYDRALAZINE 100 MG TABLET?
Since Oct 23, 2024, the NADAC for HYDRALAZINE 100 MG TABLET has ranged from a low of $0.0618 (Nov 20, 2024) to a high of $0.0832 (Nov 13, 2024), with a median of $0.0769 per EA.
Are there cheaper alternatives to HYDRALAZINE 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of HYDRALAZINE 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDRALAZINE 100 MG TABLET?
HYDRALAZINE 100 MG TABLET (NDC 72241000605) is labeled by Modavar Pharmaceuticals LLC, and CMS classifies it as a generic product.